IP Library Granted Patent US 6,939,672
Granted Patent B2
US 6,939,672 · App. 10/053,349 · Granted Sep 6, 2005

Nucleic acid extraction solution and use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,939,672
App. No.
10/053,349
Granted
Sep 6, 2005
Kind
B2
Abstract

Disclosed are methods and compositions for extracting nucleic acids from a biological sample. In particular, disclosed is a nucleic acid extraction solution together with methods using such a solution for extracting nucleic acid sequences from biological samples containing cells, cellular debris or both. The nucleic acid extraction solution contains a molecule having the formula R 1 O—CH 2 —CH 2 —OR 2 , wherein R 1 and R 2 independently are selected from the group consisting of hydrogen and an alkyl group.

Claims (17)

1. A method of extracting nucleic acid from a biological sample, the method comprising: mixing the sample with a solution comprising about 1% 2-methoxyethanol and borate buffer, so that nucleic acid is released from cells or cellular debris in the sample.

2. The method of claim 1 , wherein the solution has a pH greater than about 7.

3. The method of claim 2 , wherein the pH is greater than about 7 and less than about 13.

4. The method of claim 1 comprising the additional step of heating the mixture to a temperature within the range of from about 50° C. to about 100° C.

5. The method of claim 4 , comprising heating the mixture to a temperature of from about 75° C. to about 100° C.

6. The method claim 5 , comprising heating the mixture to a temperature of from about 90° C. to about 100° C.

7. The method of claim 1 , comprising the additional step of amplifying a nucleic acid sequence extracted from the sample.

8. The method of claim 1 , comprising the additional step of detecting a nucleic acid sequence extracted from the sample.

9. The method of claim 7 , wherein the amplification step uses a pair of amplification primers comprising the sequences of SEQ ID NOS: 4 and 5.

10. The method of claim 9 , comprising the additional step of detecting the presence of the nucleic acid sequence with a probe comprising the sequence of SEQ ID NO: 3.

11. The method of claim 7 , wherein the amplification step uses a pair of amplification primers comprising the sequences of SEQ ID NOS: 8 and 9.

12. The method of claim 11 , comprising the additional step of detecting the presence of nucleic acid sequence a probe comprising the sequence of SEQ ID NO: 10.

13. The method of claim 1 , wherein the method lacks a chloroform extraction step, a phenol extraction step, a phenol/chloroform extraction step, or an alcohol precipitation step.

14. The method of claim 1 , wherein the nucleic acid is a bacterial or viral nucleic acid.

15. The method of claim 1 , wherein the biological sample is harvested from a mammal.

16. The method of claim 15 , wherein the biological sample comprises cervical cells or cell debris.

17. The method of claim 15 , wherein the biological sample comprises breast cells or cell debris.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →